Skip to content
Lex Fridman PodcastLex Fridman Podcast

Dmitry Korkin: Computational Biology of Coronavirus | Lex Fridman Podcast #90

Dmitry Korkin is a professor of bioinformatics and computational biology at Worcester Polytechnic Institute, where he specializes in bioinformatics of complex disease, computational genomics, systems biology, and biomedical data analytics. I came across Dmitry's work when in February his group used the viral genome of the COVID-19 to reconstruct the 3D structure of its major viral proteins and their interactions with human proteins, in effect creating a structural genomics map of the coronavirus and making this data open and available to researchers everywhere. We talked about the biology of COVID-19, SARS, and viruses in general, and how computational methods can help us understand their structure and function in order to develop antiviral drugs and vaccines. Support this podcast by signing up with these sponsors: - Cash App - use code "LexPodcast" and download: - Cash App (App Store): https://apple.co/2sPrUHe - Cash App (Google Play): https://bit.ly/2MlvP5w EPISODE LINKS: Dmitry's Website: http://korkinlab.org/ Dmitry's Twitter: https://twitter.com/dmkorkin Dmitry's Paper that we discuss: https://bit.ly/3eKghEM PODCAST INFO: Podcast website: https://lexfridman.com/podcast Apple Podcasts: https://apple.co/2lwqZIr Spotify: https://spoti.fi/2nEwCF8 RSS: https://lexfridman.com/feed/podcast/ Full episodes playlist: https://www.youtube.com/playlist?list=PLrAXtmErZgOdP_8GztsuKi9nrraNbKKp4 Clips playlist: https://www.youtube.com/playlist?list=PLrAXtmErZgOeciFP3CBCIEElOJeitOr41 OUTLINE: 0:00 - Introduction 2:33 - Viruses are terrifying and fascinating 6:02 - How hard is it to engineer a virus? 10:48 - What makes a virus contagious? 29:52 - Figuring out the function of a protein 53:27 - Functional regions of viral proteins 1:19:09 - Biology of a coronavirus treatment 1:34:46 - Is a virus alive? 1:37:05 - Epidemiological modeling 1:55:27 - Russia 2:02:31 - Science bobbleheads 2:06:31 - Meaning of life CONNECT: - Subscribe to this YouTube channel - Twitter: https://twitter.com/lexfridman - LinkedIn: https://www.linkedin.com/in/lexfridman - Facebook: https://www.facebook.com/LexFridmanPage - Instagram: https://www.instagram.com/lexfridman - Medium: https://medium.com/@lexfridman - Support on Patreon: https://www.patreon.com/lexfridman

Lex FridmanhostDmitry Korkinguest
Apr 21, 20202h 9mWatch on YouTube ↗

At a glance

WHAT IT’S REALLY ABOUT

Decoding Coronavirus: Computational Maps, Viral Evolution, and Pandemic Control

  1. Lex Fridman talks with computational biologist Dmitry Korkin about how bioinformatics and structural genomics are being used to understand SARS-CoV-2 and related viruses.
  2. Korkin explains how his team rapidly modeled the 3D structures and interactions of coronavirus proteins using the viral genome and existing structural data, highlighting conserved drug-binding regions and mutation patterns.
  3. They discuss the biology of viral infection, protein folding, prospects for antivirals and universal vaccines, and how open data and global scientific collaboration have accelerated COVID-19 research.
  4. The conversation also touches on agent‑based epidemic simulations, the role of asymptomatic spread, the ethics and risks of engineered viruses, and reflections on human fragility in the face of simple yet powerful pathogens.

IDEAS WORTH REMEMBERING

5 ideas

Computational models can rapidly map the structure of new viruses using existing data.

Once the genome of SARS-CoV-2 was released, Korkin’s group could infer 3D structures for many of its 29 proteins by homology to known coronavirus proteins, identifying functional sites and interaction patterns long before full experimental structures were available.

Many key drug-binding sites in SARS-CoV-2 are conserved from SARS, enabling drug repurposing.

By comparing sequences and projected structures, they found that regions where known small molecules bind in SARS and MERS are largely unchanged in SARS-CoV-2, suggesting existing antivirals (e.g., Remdesivir, protease inhibitors) may still be effective targets.

Viral evolution is highly uneven across the genome, focusing on specific proteins and regions.

The team observed that some viral proteins are almost identical to their SARS/bat counterparts while others are heavily mutated, and that in 3D these mutations often cluster at functional or interaction sites, offering clues about changes in infectivity or host range.

Asymptomatic and pre-symptomatic transmission fundamentally changes epidemic control.

COVID-19’s long incubation and significant asymptomatic shedding make traditional containment (based mainly on symptom screening and isolation) much less effective, underscoring the importance of masks, distancing, and models that explicitly account for this phase.

Agent-based models that include explicit pathogen behavior can test intervention strategies.

Korkin’s group built multi-agent simulations (originally on cruise ships) where both humans and the virus are modeled as agents with behaviors (shedding rates, surface survival, transmission modes), allowing scenario testing for different diseases and control policies.

WORDS WORTH SAVING

5 quotes

“The virus itself… it’s not a living organism. It’s a machine… an intelligent machine.”

Dmitry Korkin

“We should benefit tremendously by understanding the mechanisms by which the virus can jump… because all these answers would eventually lead to designing better vaccines. Hopefully universal vaccines.”

Dmitry Korkin

“If you take this new virus and you take the closest relatives… the evolution is not occurring uniformly across the entire viral genome, but actually targets very specific proteins.”

Dmitry Korkin

“Our understanding of the molecular mechanisms will allow us to have more efficient designs of vaccines. However, once you design the vaccine, it needs to be tested.”

Dmitry Korkin

“It certainly makes me realize how fragile the human life is… we are fragile. We have to bond together as a society.”

Dmitry Korkin

Biology and structure of SARS-CoV-2 and related coronavirusesComputational modeling of viral proteins and protein–protein interactionsDrug repurposing, antiviral targets, and prospects for universal vaccinesProtein folding, machine learning (e.g., AlphaFold), and the Protein Data BankAgent-based epidemic simulations and the dynamics of asymptomatic spreadNatural versus engineered pandemics and biosecurity considerationsOpen science, rapid data sharing, and the collaborative COVID-19 research response

High quality AI-generated summary created from speaker-labeled transcript.

Get more out of YouTube videos.

High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.

Add to Chrome